LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 180

Search options

  1. Book: Tête et rachis cervical supérieur

    Lioté, Frédéric

    (Revue du rhumatisme : Monographies ; 80,1)

    2013  

    Author's details nr. coordonné par Frédéric Lioté
    Series title Revue du rhumatisme : Monographies ; 80,1
    Revue du rhumatisme
    Revue du rhumatisme ; Monographies
    Collection Revue du rhumatisme
    Revue du rhumatisme ; Monographies
    Language French
    Size 71 S. : zahlr. Ill.
    Publisher Elsevier Masson
    Publishing place Issy-les-Moulineaux
    Publishing country Netherlands
    Document type Book
    HBZ-ID HT017588888
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book: Miscellaneous non-inflammatory musculokeletal conditions

    Lioté, Frédéric / Punzi, Leonardo

    (Best practice & research : Clinical rheumatology ; 25,5)

    2011  

    Author's details Frédéric Lioté ; Leonardo Punzi, guest ed
    Series title Best practice & research : Clinical rheumatology ; 25,5
    Best practice & research
    Best practice & research ; Clinical rheumatology
    Collection Best practice & research
    Best practice & research ; Clinical rheumatology
    Language English
    Size S. 625 - 747 : Ill., graph. Darst.
    Publisher Elsevier
    Publishing place Amsterdam u.a.
    Publishing country Netherlands
    Document type Book
    HBZ-ID HT017084489
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  3. Article ; Online: Gout furonculosis.

    Lioté, Frédéric

    Joint bone spine

    2018  Volume 86, Issue 1, Page(s) 103

    MeSH term(s) Aged ; Female ; Gout/complications ; Gout/diagnosis ; Gout/pathology ; Humans ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/drug therapy ; Skin Diseases, Metabolic/diagnosis ; Skin Diseases, Metabolic/etiology ; Skin Diseases, Metabolic/pathology
    Language English
    Publishing date 2018-05-19
    Publishing country France
    Document type Case Reports ; Journal Article
    ZDB-ID 2020487-5
    ISSN 1778-7254 ; 1297-319X
    ISSN (online) 1778-7254
    ISSN 1297-319X
    DOI 10.1016/j.jbspin.2018.05.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Mechanisms and rationale for uricase use in patients with gout.

    Schlesinger, Naomi / Pérez-Ruiz, Fernando / Lioté, Frédéric

    Nature reviews. Rheumatology

    2023  Volume 19, Issue 10, Page(s) 640–649

    Abstract: Xanthine oxidase inhibitors such as allopurinol and febuxostat have been the mainstay urate-lowering therapy (ULT) for treating hyperuricaemia in patients with gout. However, not all patients receiving oral ULT achieve the target serum urate level, in ... ...

    Abstract Xanthine oxidase inhibitors such as allopurinol and febuxostat have been the mainstay urate-lowering therapy (ULT) for treating hyperuricaemia in patients with gout. However, not all patients receiving oral ULT achieve the target serum urate level, in part because some patients cannot tolerate, or have actual or misconceived contraindications to, their use, mainly due to comorbidities. ULT dosage is also limited by formularies and clinical inertia. This failure to sufficiently lower serum urate levels can lead to difficult-to-treat or uncontrolled gout, usually due to poorly managed and/or under-treated gout. In species other than humans, uricase (urate oxidase) converts urate to allantoin, which is more soluble in urine than uric acid. Exogenic uricases are an exciting therapeutic option for patients with gout. They can be viewed as enzyme replacement therapy. Uricases are being used to treat uncontrolled gout, and can achieve rapid reduction of hyperuricaemia, dramatic resolution of tophi, decreased chronic joint pain and improved quality of life. Availability, cost and uricase immunogenicity have limited their use. Uricases could become a leading choice in severe and difficult-to-treat gout as induction and/or debulking therapy (that is, for lowering of the urate pool) to be followed by chronic oral ULT. This Review summarizes the evidence regarding available uricases and those in the pipeline, their debulking effect and their outcomes related to gout and beyond.
    MeSH term(s) Humans ; Gout Suppressants/therapeutic use ; Gout Suppressants/adverse effects ; Uric Acid ; Hyperuricemia/complications ; Hyperuricemia/drug therapy ; Urate Oxidase/therapeutic use ; Quality of Life ; Gout/drug therapy ; Allopurinol/therapeutic use ; Allopurinol/adverse effects
    Chemical Substances Gout Suppressants ; Uric Acid (268B43MJ25) ; Urate Oxidase (EC 1.7.3.3) ; Allopurinol (63CZ7GJN5I)
    Language English
    Publishing date 2023-09-08
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2491532-4
    ISSN 1759-4804 ; 1759-4790
    ISSN (online) 1759-4804
    ISSN 1759-4790
    DOI 10.1038/s41584-023-01006-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Methotrexate also improves rheumatoid arthritis through correction of microbiota dysbiosis.

    Berthelot, Jean-Marie / Lioté, Frédéric / Sibilia, Jean

    Joint bone spine

    2023  Volume 90, Issue 5, Page(s) 105602

    MeSH term(s) Humans ; Methotrexate/therapeutic use ; Dysbiosis ; Arthritis, Rheumatoid/drug therapy ; Microbiota
    Chemical Substances Methotrexate (YL5FZ2Y5U1)
    Language English
    Publishing date 2023-06-22
    Publishing country France
    Document type Editorial
    ZDB-ID 2020487-5
    ISSN 1778-7254 ; 1297-319X
    ISSN (online) 1778-7254
    ISSN 1297-319X
    DOI 10.1016/j.jbspin.2023.105602
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: New therapeutic approach to hyperuricemia and gout in the light of recommendations.

    Lioté, Frédéric

    Joint bone spine

    2016  Volume 83, Issue 4, Page(s) 376–380

    MeSH term(s) Europe ; Female ; Gout/blood ; Gout/drug therapy ; Gout Suppressants/therapeutic use ; Humans ; Hyperuricemia/diagnosis ; Hyperuricemia/drug therapy ; Male ; Monitoring, Physiologic/methods ; Practice Guidelines as Topic ; Uric Acid/blood
    Chemical Substances Gout Suppressants ; Uric Acid (268B43MJ25)
    Language English
    Publishing date 2016-04-13
    Publishing country France
    Document type Editorial
    ZDB-ID 2020487-5
    ISSN 1778-7254 ; 1297-319X
    ISSN (online) 1778-7254
    ISSN 1297-319X
    DOI 10.1016/j.jbspin.2016.02.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Constriction ring syndrome: Severe cuts.

    Pezot, Mathilde / Funck-Brentano, Thomas / Lioté, Frédéric

    Joint bone spine

    2022  Volume 89, Issue 6, Page(s) 105415

    MeSH term(s) Humans ; Constriction
    Language English
    Publishing date 2022-05-27
    Publishing country France
    Document type Journal Article
    ZDB-ID 2020487-5
    ISSN 1778-7254 ; 1297-319X
    ISSN (online) 1778-7254
    ISSN 1297-319X
    DOI 10.1016/j.jbspin.2022.105415
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Butterfly vertebra.

    Vivier, Magdaline / Attane, Grégoire / Fabre, Stéphanie / Lioté, Frédéric

    Joint bone spine

    2022  Volume 90, Issue 2, Page(s) 105506

    MeSH term(s) Humans ; Spinal Diseases ; Lumbar Vertebrae/diagnostic imaging
    Language English
    Publishing date 2022-12-06
    Publishing country France
    Document type Journal Article
    ZDB-ID 2020487-5
    ISSN 1778-7254 ; 1297-319X
    ISSN (online) 1778-7254
    ISSN 1297-319X
    DOI 10.1016/j.jbspin.2022.105506
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: COVID-19 as a STING disorder with delayed over-secretion of interferon-beta.

    Berthelot, Jean-Marie / Lioté, Frédéric

    EBioMedicine

    2020  Volume 56, Page(s) 102801

    MeSH term(s) Animals ; Betacoronavirus/isolation & purification ; COVID-19 ; Chiroptera/virology ; Coronavirus Infections/metabolism ; Coronavirus Infections/pathology ; Coronavirus Infections/virology ; Humans ; Interferon Regulatory Factor-3/metabolism ; Interferon-beta/metabolism ; Membrane Proteins/metabolism ; NF-kappa B/metabolism ; Pandemics ; Pneumonia, Viral/metabolism ; Pneumonia, Viral/pathology ; Pneumonia, Viral/virology ; Risk ; SARS-CoV-2 ; Severity of Illness Index
    Chemical Substances IRF3 protein, human ; Interferon Regulatory Factor-3 ; Membrane Proteins ; NF-kappa B ; STING1 protein, human ; Interferon-beta (77238-31-4)
    Keywords covid19
    Language English
    Publishing date 2020-05-23
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2851331-9
    ISSN 2352-3964
    ISSN (online) 2352-3964
    DOI 10.1016/j.ebiom.2020.102801
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: A prospective survey on therapeutic inertia in psoriatic arthritis (OPTI'PsA).

    Lioté, Frédéric / Constantin, Arnaud / Dahan, Étienne / Quiniou, Jean-Baptiste / Frazier, Aline / Sibilia, Jean

    Rheumatology (Oxford, England)

    2023  Volume 63, Issue 2, Page(s) 516–524

    Abstract: Objectives: Clinical inertia, or therapeutic inertia (TI), is the medical behaviour of not initiating or intensifying treatment when recommended by clinical recommendations. To our knowledge, our survey is the first to assess TI around psoriatic ... ...

    Abstract Objectives: Clinical inertia, or therapeutic inertia (TI), is the medical behaviour of not initiating or intensifying treatment when recommended by clinical recommendations. To our knowledge, our survey is the first to assess TI around psoriatic arthritis (PsA).
    Methods: Eight hundred and twenty-five French rheumatologists were contacted via email between January and March 2021 and invited to complete an online questionnaire consisting of seven clinical vignettes: five cases ('oligoarthritis', 'enthesitis', 'polyarthritis', 'neoplastic history', 'cardiovascular risk') requiring treatment OPTImization, and two 'control' cases (distal interphalangeal arthritis, atypical axial involvement) not requiring any change of treatment-according to the most recent PsA recommendations. Rheumatologists were also questioned about their routine practice, continuing medical education and perception of PsA.
    Results: One hundred and one rheumatologists completed this OPTI'PsA survey. Almost half the respondents (47%) demonstrated TI on at least one of the five vignettes that warranted treatment optimization. The complex profiles inducing the most TI were 'oligoarthritis' and 'enthesitis' with 20% and 19% of respondents not modifying treatment, respectively. Conversely, clinical profiles for which there was the least uncertainty ('polyarthritis in relapse', 'neoplastic history' and 'cardiovascular risk') generated less TI with 11%, 8% and 6% of respondents, respectively, choosing not to change the current treatment.
    Conclusion: The rate of TI we observed for PsA is similar to published data for other chronic diseases such as diabetes, hypertension, gout or multiple sclerosis. Our study is the first to show marked clinical inertia in PsA, and further research is warranted to ascertain the reasons behind this inertia.
    MeSH term(s) Humans ; Arthritis, Psoriatic ; Prospective Studies ; Rheumatologists ; Hypertension ; Surveys and Questionnaires ; Enthesopathy
    Language English
    Publishing date 2023-06-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/kead262
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top